S&P 500
(0.25%) 5 487.03 points
Dow Jones
(0.15%) 38 835 points
Nasdaq
(0.03%) 17 862 points
Oil
(0.12%) $81.67
Gas
(-0.03%) $2.91
Gold
(-0.13%) $2 343.90
Silver
(0.02%) $29.57
Platinum
(0.06%) $977.80
USD/EUR
(0.05%) $0.931
USD/NOK
(0.05%) $10.58
USD/GBP
(0.03%) $0.787
USD/RUB
(-0.15%) $85.24

Realtime updates for DexCom Inc [DXCM]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
BUY
80.00%
return 5.79%
SELL
20.00%
return 3.10%
Last Updated18 Jun 2024 @ 16:00

0.09% $ 116.64

BUY 273 min ago

@ $116.82

Issued: 18 Jun 2024 @ 15:55


Return: -0.15%


Previous signal: Jun 18 - 14:55


Previous signal: Sell


Return: -0.37 %

Live Chart Being Loaded With Signals

Commentary (18 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -0.01% compare to its pairs and should correct downwards.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally...

Stats
Today's Volume 2.19M
Average Volume 2.64M
Market Cap 46.39B
EPS $0.380 ( Q1 | 2024-04-25 )
Next earnings date ( $0.390 ) 2024-07-25
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 75.74
(Sector) 42.63
(Industry) 0
ATR14 $1.290 (1.11%)
AEMD 5.37%
AFIB 6.44%
AHCO -0.35%
AHPI 0.00%
ALGN -1.35%
ANIK -0.23%
APEN 0.00%
APYX -7.48%
ARAY -6.95%
ATEC -0.95%
AXDX -9.38%
AXGN -3.51%
AXNX 0.34%
AZYO 2.05%
BBLG -2.61%
BIOL -13.19%
BJDX -9.61%
BMRA -9.90%
BRKR 2.99%
BSGM -15.38%
BWAY 1.00%
CERS -6.63%
CFMS 0.44%
CLPT -2.60%
CODX 5.52%
CSII 0.15%
CTKB -1.23%
CTSO -9.51%
CUTR -1.81%
CVRX 0.82%
DCTH -1.16%
DXCM 0.09%
DYNT -6.19%
EAR -4.10%
ECOR -5.72%
EDAP -1.41%
ESTA 0.67%
FONR -0.59%
HJLI -1.98%
HSDT -3.30%
HSKA 0.00%
HYPR -2.19%
IART 0.35%
ICAD -2.68%
ICCM 2.48%
IINN -8.43%
INGN 5.16%
INMD -5.17%
IRIX -5.95%
IRMD -1.70%
IRTC 2.52%
ISO 0.00%
ITMR 0.00%
KIDS 1.77%
LHDX 0.00%
LIVN 0.89%
LNSR -4.12%
LUCD 1.63%
LUNG 0.17%
MASS -3.51%
MDGS 10.28%
MOTS 6.84%
MOVE -5.12%
MSON 0.00%
NAOV -4.10%
NARI 5.09%
NMRD 0.00%
NNOX -4.18%
NPCE 0.00%
NTUS 0.00%
NURO -1.72%
NUVA -2.24%
NUWE 17.03%
NVCN 0.00%
NVNO -3.89%
OBLN -5.86%
OFIX 2.39%
OM -2.15%
PACB -1.50%
PAVM -8.42%
PETV -10.17%
PODD -1.01%
PRCT -0.06%
PROF 5.64%
QIPT 0.31%
QTRX -1.92%
RCEL -1.35%
RPID -1.28%
RSLS -4.52%
RWLK 6.07%
RXST 1.71%
SGHT -0.78%
SIBN -0.88%
SIEN -18.69%
SILK 24.04%
SINT -4.95%
SOLY 0.00%
SRDX 0.07%
SRGA 0.00%
SRTS -1.15%
SWAV 0.00%
TBIO 2.16%
TCMD -2.13%
TELA -8.30%
THMO -25.07%
TIVC -4.56%
TLIS -3.60%
TMCI -0.82%
TMDI 0.00%
TMDX 2.02%
TNDM -0.40%
TNON -6.09%
UFPT 1.14%
VERO 8.14%
VIVE 0.00%
VMD -3.64%
VRAY 0.00%
VREX 0.33%
VVOS 2.40%
XAIR -3.82%
XENT 0.00%
ZIMV 0.32%
Insider Trading
Date Person Action Amount type
2024-06-14 Heller Bridgette P Sell 1 000 Common Stock
2024-06-10 Sylvain Jereme M Sell 745 Common Stock
2024-06-10 Stern Sadie Sell 427 Common Stock
2024-06-10 Leach Jacob Steven Sell 745 Common Stock
2024-05-31 Brown Michael Jon Sell 652 Common Stock
INSIDER POWER
-0.85
Last 100 transactions
Buy: 336 995 | Sell: 344 022
Correlation (AI algo v.1.1b): Overvalued: -0.01% $116.73 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.33 (neutral)
Short: -0.79 (moderate negative)
Signal:(25) Neutral

DexCom Inc Correlation

10 Most Positive Correlations
CAPR0.847
KRYS0.828
STER0.813
ACMR0.803
HCWB0.801
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DexCom Inc Correlation - Currency/Commodity

The country flag -0.36
( neutral )
The country flag -0.38
( neutral )
The country flag 0.06
( neutral )
The country flag 0.34
( neutral )
The country flag -0.38
( neutral )
The country flag 0.73
( moderate )

DexCom Inc Financials

Annual 2023
Revenue: $3.62B
Gross Profit: $2.29B (63.19 %)
EPS: $1.400
FY 2023
Revenue: $3.62B
Gross Profit: $2.29B (63.19 %)
EPS: $1.400
FY 2022
Revenue: $2.91B
Gross Profit: $1.88B (64.72 %)
EPS: $0.880
FY 2021
Revenue: $2.45B
Gross Profit: $1.68B (68.63 %)
EPS: $0.400

Financial Reports:

No articles found.

DexCom Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 0.99487996101379 seconds
Number of API calls: 3
Number of DB calls: 9